ADENOCARCINOMA
Clinical trials for ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Modified immune cells target tough cancers in groundbreaking trial
Disease control Recruiting nowThis early-stage study is testing a new cell therapy for people with advanced ovarian or pancreatic cancer that has stopped responding to standard treatments. Doctors are giving patients specially modified immune cells, called CAR-NK cells, directly into the abdomen to try to att…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
First trial tests Genetic-Guided 'Chemo Cocktail' for tough cancers
Disease control Recruiting nowThis early-stage study aims to find the safest dose of a powerful combination of five chemotherapy drugs for people with advanced cancers of the stomach, pancreas, and related areas. It uses a patient's genetic test results to personalize the dose of one key drug, hoping to reduc…
Matched conditions: ADENOCARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Radical surgery trial aims to boost cervical cancer survival rates
Disease control Recruiting nowThis international study is testing whether adding a specific lymph node surgery before standard chemoradiation treatment helps patients with advanced cervical cancer live longer without their cancer returning. The trial will compare two approaches: standard treatment alone versu…
Matched conditions: ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Institut Claudius Regaud • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Doctors train Patients' own cells to fight lung cancer in new trial
Disease control Recruiting nowThis study is testing a personalized cell therapy for adults with advanced non-small cell lung cancer that has stopped responding to standard treatments. Doctors remove a patient's tumor, grow special immune cells from it in a lab, and then infuse a large number of these 'tumor-f…
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
New hope for tough cancer: drug combo trial seeks to control advanced pancreatic disease
Disease control Recruiting nowThis study is testing whether adding an oral drug called relacorilant to two standard chemotherapy drugs can help control advanced pancreatic cancer that has spread. It will involve about 60 adults whose cancer has not yet been treated. The main goal is to see if this three-drug …
Matched conditions: ADENOCARCINOMA
Phase: PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Massive 12,000-Patient study aims to unlock secrets of lung cancer survival
Knowledge-focused Recruiting nowThis study aims to collect detailed information on 12,000 patients with lung and other chest cancers over many years. By tracking their treatments, health, and quality of life, researchers hope to understand why outcomes vary so much between patients. The goal is to use this real…
Matched conditions: ADENOCARCINOMA
Sponsor: Dutch Society of Physicians for Pulmonology and Tuberculosis • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:34 UTC
-
New scan could predict best cancer treatment
Knowledge-focused Recruiting nowThis study is testing a new type of PET scan to see if it can help doctors predict which chemotherapy drugs might work best for a patient's metastatic cancer. A small number of participants with advanced cancer will receive an injection of an experimental imaging agent and then h…
Matched conditions: ADENOCARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Roberto Vargas • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Massive study aims to unlock why prostate cancer behaves differently in different people
Knowledge-focused Recruiting nowThis study aims to understand why prostate cancer progresses slowly in some men but aggressively in others. Researchers will follow 3,000 newly diagnosed patients in France and the Caribbean, collecting information about their genetics, lifestyle, and environment. The goal is to …
Matched conditions: ADENOCARCINOMA
Phase: NA • Sponsor: Centre Hospitalier Universitaire de la Guadeloupe • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:29 UTC